Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Impaired Carotid Baroreflex Control of Arterial Blood Pressure in Multiple Sclerosis.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice.
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Elderly-onset neuromyelitis optica spectrum disorders.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
[Teriflunomide for treatment of multiple sclerosis.]
Pediatric inflammatory diseases. Part I: multiple sclerosis.
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.
We-Measure: Toward a low-cost portable posturography for patients with multiple sclerosis using the commercial Wii balance board.
Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Pain in acquired inflammatory demyelinating polyneuropathies.
Highlights from this issue.
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.

Pages